NHS AAA Screening Programme Data Linkage With HES and ONS Datasets
1 other identifier
observational
1,000,000
1 country
1
Brief Summary
An abdominal aortic aneurysm (AAA) is a dilation of the aorta, defined as an aortic diameter of ≥3cm. It is a significant cause of death internationally and in England each year causes c.4,000 deaths with 8,000 patients undergoing preventative surgery. AAA are often asymptomatic and there is a latent period between development and rupture. This represents an opportunity to screen by ultrasound which has been shown in trials to reduce AAA related mortality by half. In England this evidence is based on a randomised trial data from the late nineties, however, since these data were published the number of men identified with AAA has fallen to a current prevalence of just over 1%. Furthermore, similarly designed randomised trials in Western Australia demonstrated no meaningful differences in AAA or cardiovascular deaths. The first aim of our research is to follow men who have been screened for AAA in England in order to establish the medium (5 years) and long term (10+ years) impact of AAA screening on the risk of a AAA, cardiovascular and all-cause morbidity/mortality in a non-trial setting. Men with sub-aneurysms will be examined (Aorta=2.5-2.9cm) as several studies suggest this group is at risk of late rupture. The role of patient pathways to improve uptake of the screening programme will be examined. Current data suggests that the most 'deprived' men in England are the least likely to turn up for screening but the most likely to have an abdominal aneurysm. Outcomes in this group will be analysed including the benefit of a new patient pathway to improve uptake nationally. Lastly, several large studies have demonstrated that a larger aortic diameter may be associated with cardiovascular risk. The addition of aortic diameter to current risk prediction models could improve the accuracy of these models and will be examined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2017
CompletedFirst Posted
Study publicly available on registry
January 23, 2018
CompletedStudy Start
First participant enrolled
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2021
CompletedMarch 10, 2020
January 1, 2020
6 months
December 13, 2017
March 8, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
AAA related mortality in men invited for AAA screening
Mortality
10 years
AAA related morbidity in men invited for AAA screening
Admissions to Hospital
10 years
Secondary Outcomes (3)
Medium term mortality
5 years
Cardiovascular risk in men screened for AAA
10 years
Medium term morbidity
5 years
Study Arms (1)
Men Screened for AAA in England
Men invited into the NHS AAA Screening programme in England in the years 2013-2017.
Interventions
We will not be testing an intervention. Only the long term outcomes of men screened for AAA in England.
Eligibility Criteria
Men screened for AAA within the NHS AAA Screening programme in England for the period covering 2013-2017; specifically, screening years 2013/14, 2014/15, 2015/16 and 2016/17.
You may qualify if:
- All men invited to the NHS AAA screening programme in England between the period of 2013-2017
- Aged 65 years of age at the time of their invitation to the NHS AAA screening programme
- All men who have consented for their data to be used for the purposes of research
You may not qualify if:
- \. All men who do not consent for their data to be used for the purposes of research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Leicester
Leicester, LE3 9QP, United Kingdom
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 13, 2017
First Posted
January 23, 2018
Study Start
July 1, 2020
Primary Completion
January 1, 2021
Study Completion
January 1, 2021
Last Updated
March 10, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share
Data will be anonymised and no patient data will be passed outside of the research group. Results will be published in the usual way.